Baxter Kidney Patient Education Program Celebrates Tenth A... (rowing prevalence of CKD has led to an i...)

Baxter Kidney Patient Education Program Celebrates Tenth Anniversary

Date:11/5/2007

rowing prevalence of CKD has led to an increased need for patient education. The National Kidney Foundation estimates that at least 20 million Americans have CKD and 20 million more are at risk. About 400,000 patients have been diagnosed with End-Stage Renal Disease (ESRD), which requires dialysis or a kidney transplant to stay alive, and the number is projected to rise to more than 660,000 by 2010.

This growth in kidney dialysis patients has created a need for not only reliable information, but for professionals who can translate medical information into simple, understandable terms. A CKD patient transitioning to ongoing dialysis treatment has to quickly learn complicated medical concepts and how to ask their doctor the right questions about their care options. A KPE provides a valuable indirect service to nephrologists and nurses by accelerating patient understanding and following up with patients as they weigh their treatment options and consider lifestyle implications.

"When we first meet a patient, we reinforce what the nephrologist has already told them about kidney disease and provide additional information," said Barbour. "Later, we call to see if they have any questions we can answer, so that when they go back to see their doctor, they can have a more informed conversation on what they need to do and why. We continue to follow-up until they begin their therapy, to address additional specific questions and concerns that they may have."

This support is especially important for chronic kidney diseases that have no cure and where ongoing life-sustaining treatment is needed. Numerous research studies on patient education have shown that patients who are actively involved in making and understanding decisions about their therapy have better health outcomes and better adherence to their treatment plan.(1) Other studies have shown that patients who are educated and knowledgeable about their condition and treatment options have fewer complications
'/>"/>

1

GOOD

Page: 1 2 3 4
Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
8. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
9. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain

Post Your Comments:

Baxter Kidney Patient Education Program Celebrates Tenth A...(rowing prevalence of CKD has led to an i...)